Kellerborg K - Search Results

1

Budget impact models for lung cancer interventions: A systematic literature review.

Willis M, Nilsson A, Kellerborg K, Lwin ZMT, Prelaj A. Willis M, et al. Among authors: kellerborg k. J Manag Care Spec Pharm. 2024 Sep;30(9):1041-1056. doi: 10.18553/jmcp.2024.30.9.1041. J Manag Care Spec Pharm. 2024. PMID: 39213147 Free PMC article.

2

Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life.

Norlin JM, Kellerborg K, Persson U, Åström DO, Hagell P, Martinez-Martin P, Odin P. Norlin JM, et al. Among authors: kellerborg k. Mov Disord Clin Pract. 2023 Jan 20;10(3):392-398. doi: 10.1002/mdc3.13649. eCollection 2023 Mar. Mov Disord Clin Pract. 2023. PMID: 36949801 Free PMC article.

3

The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based Study.

Kellerborg K, Norlin JM, Odin P. Kellerborg K, et al. Mov Disord Clin Pract. 2022 Dec 15;10(2):231-237. doi: 10.1002/mdc3.13630. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825055 Free PMC article.

4

High risk of developing dementia in Parkinson's disease: a Swedish registry-based study.

Åström DO, Simonsen J, Raket LL, Sgarbi S, Hellsten J, Hagell P, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P. Åström DO, et al. Among authors: kellerborg k. Sci Rep. 2022 Oct 6;12(1):16759. doi: 10.1038/s41598-022-21093-8. Sci Rep. 2022. PMID: 36202962 Free PMC article.

5

Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease.

Raket LL, Oudin Åström D, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P. Raket LL, et al. Among authors: kellerborg k. Sci Rep. 2022 Jan 11;12(1):526. doi: 10.1038/s41598-021-04356-8. Sci Rep. 2022. PMID: 35017548 Free PMC article.

6

Estimating the costs of non-medical consumption in life-years gained for economic evaluations.

Kellerborg K, Wouterse B, Brouwer W, van Baal P. Kellerborg K, et al. Soc Sci Med. 2021 Nov;289:114414. doi: 10.1016/j.socscimed.2021.114414. Epub 2021 Sep 20. Soc Sci Med. 2021. PMID: 34563871

7

Distributional consequences of including survivor costs in economic evaluations.

Kellerborg K, Brouwer W, Versteegh M, Wouterse B, van Baal P. Kellerborg K, et al. Health Econ. 2021 Sep;30(10):2606-2613. doi: 10.1002/hec.4401. Epub 2021 Jul 30. Health Econ. 2021. PMID: 34331343 Free PMC article.

8

Parkinson's disease in Sweden-resource use and costs by severity.

Hjalte F, Norlin JM, Kellerborg K, Odin P. Hjalte F, et al. Among authors: kellerborg k. Acta Neurol Scand. 2021 Nov;144(5):592-599. doi: 10.1111/ane.13502. Epub 2021 Jul 12. Acta Neurol Scand. 2021. PMID: 34254292

9

Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

Norlin JM, Kellerborg K, Odin P. Norlin JM, et al. Among authors: kellerborg k. Pharmacoeconomics. 2021 Oct;39(10):1141-1149. doi: 10.1007/s40273-021-01056-z. Epub 2021 Jul 7. Pharmacoeconomics. 2021. PMID: 34231134

10

Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands.

de Vries LM, Kellerborg KM, Brouwer WBF, van Baal PHM. de Vries LM, et al. Among authors: kellerborg km. Vaccine. 2021 Jun 29;39(29):3834-3843. doi: 10.1016/j.vaccine.2021.05.091. Epub 2021 Jun 9. Vaccine. 2021. PMID: 34116878 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters